DBV Technologies S.A. (DBVT) Ownership
DBVT ownership summary
as of October 18, 2026- Institutions
- 41.6% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 62.8M
- Float
- 31.9M shares available to trade
- Short interest
- 1.79% 1.1M shares short
- Days to cover
- 3.29 short interest down 16.9% vs prior month
- Institutions 41.62%
- Other investors 58.38%
DBVT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | MPM Oncology Impact Management LP | 5.83% | 3.7M | $33.2M | −1.5M (−29.7%) | June 30, 2026 |
| 2 | Siren, L.L.C. | 2.96% | 1.9M | $16.8M | — | June 30, 2026 |
| 3 | Vivo Capital, LLC | 2.94% | 1.8M | $16.7M | −822,811 (−30.8%) | June 30, 2026 |
| 4 | Perceptive Advisors LLC | 2.63% | 1.7M | $15.0M | +688,959 (+71.4%) | June 30, 2026 |
| 5 | Baker Bros Advisors LP | 2.33% | 1.5M | $13.2M | — | June 30, 2026 |
| 6 | Artisan Partners Limited Partnership | 2.18% | 1.4M | $12.4M | −846,535 (−38.1%) | June 30, 2026 |
| 7 | UBS Group AG | 2.09% | 1.3M | $11.9M | +1.2M (+1,551.4%) | June 30, 2026 |
| 8 | Morgan Stanley - Brokerage Accounts | 1.52% | 955K | $8.6M | +808,792 (+553.5%) | June 30, 2026 |
| 9 | Logos Global Management LP | 1.46% | 915K | $8.3M | +915,000 (0.0%) | June 30, 2026 |
| 10 | Patient Square Capital LP | 1.45% | 909K | $8.2M | +215,940 (+31.1%) | June 30, 2026 |
| 11 | Octagon Capital Advisors LP | 0.91% | 574K | $5.2M | — | June 30, 2026 |
| 12 | ADAR1 Capital Management LLC | 0.84% | 528K | $4.8M | −484,571 (−47.8%) | June 30, 2026 |
| 13 | Ikarian Capital, LLC | 0.84% | 525K | $4.8M | — | June 30, 2026 |
| 14 | Redmile Group, LLC | 0.65% | 410K | $3.7M | −80,900 (−16.5%) | June 30, 2026 |
| 15 | Duquesne Family Office LLC | 0.61% | 383K | $3.5M | — | June 30, 2026 |
| 16 | Ameriprise Financial Inc | 0.60% | 378K | $3.4M | +147,080 (+63.6%) | June 30, 2026 |
| 17 | Millennium Management LLC | 0.43% | 268K | $2.4M | −51,176 (−16.0%) | June 30, 2026 |
| 18 | Elmind Capital LP | 0.42% | 265K | $2.4M | — | June 30, 2026 |
| 19 | Jane Street Group LLC | 0.36% | 224K | $2.0M | +212,630 (+1,884.2%) | June 30, 2026 |
| 20 | Ishara Investments LP | 0.29% | 184K | $1.7M | +82,000 (+80.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 4.3M shares and 6 cut 3.8M.
DBVT top mutual fund and ETF holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Artisan International Small-Mid Investor | 1.78% | 1.1M | $10.1M | +277,560 (+33.0%) | September 30, 2026 |
| 2 | Fidelity Advisor Biotechnology I | 0.68% | 429K | $3.9M | — | August 31, 2026 |
| 3 | DWS ESG Biotech LC | 0.09% | 59K | $536,140 | — | August 31, 2026 |
| 4 | A4Investments SICAV SIF ACCI IlanaA2EURH | 0.04% | 25K | $226,250 | — | September 30, 2026 |
| 5 | Russell Inv US Small Cap Equity Y | 0.04% | 23K | $205,498 | — | August 31, 2026 |
| 6 | China Universal Gbl YLBJ QDII CNH | 0.01% | 8,000 | $72,400 | +8,000 (0.0%) | June 30, 2026 |
| 7 | ActivePassive International Equity ETF | 0.01% | 6,265 | $56,698 | — | September 30, 2026 |
| 8 | Russell Inv US Small Cap Equity | 0.01% | 5,834 | $52,798 | — | August 31, 2026 |
| 9 | Steward Values Enhanced International I | 0.01% | 4,051 | $36,662 | — | August 31, 2026 |
| 10 | Lord Abbett Health Care R6 | <0.01% | 2,973 | $26,906 | — | August 31, 2026 |
| 11 | Fidelity Nasdaq Composite Index | <0.01% | 1,509 | $13,656 | −11,346 (−88.3%) | August 31, 2026 |
| 12 | Lord Abbett Global Hlth Cr IF GBP Acc | <0.01% | 974 | $8,815 | — | August 31, 2026 |
| 13 | Gabelli Health & Wellness | <0.01% | 400 | $3,620 | −400 (−50.0%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
DBVT insider transactions
latest 5| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-29 | Pharis Mohideen | Sell | $4.86 | 534 | $2,595 |
| 2025-12-18 | Bpifrance Epic | Sell | $4.19 | 1,292,103 | $5.4M |
| 2025-12-17 | Bpifrance Epic | Sell | $4.85 | 2,076,990 | $10.1M |
| 2025-07-29 | Pharis Mohideen | Sell | $2.22 | 464 | $1,030 |
| 2025-05-22 | Pharis Mohideen | Sell | $1.84 | 397 | $730 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
DBVT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns DBVT
Institutional investors own 41.6% of DBV Technologies's shares and insiders 0.00%. The largest holder is MPM Oncology Impact Management LP with 5.83% of the shares (3.7M), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 6 reduced their stake in the latest filings. Short interest is 1.79% of the float, or 3.29 days of average trading volume. The share count rose 2,168.9% since 2014.
Related: DBVT analyst forecast, DBVT key metrics. See the DBVT stock overview for the latest quote and news.
DBVT ownership FAQ
Who owns the most DBV Technologies stock?
The largest shareholders of DBV Technologies are MPM Oncology Impact Management LP (5.83%), Siren, L.L.C. (2.96%), Vivo Capital, LLC (2.94%), Perceptive Advisors LLC (2.63%), Baker Bros Advisors LP (2.33%).
What percentage of DBV Technologies is owned by institutions?
Institutions hold 41.6% of DBV Technologies's shares outstanding; insiders hold 0.00%.
Which funds own DBV Technologies?
The largest fund holders of DBV Technologies are Artisan International Small-Mid Investor (1.78%), Fidelity Advisor Biotechnology I (0.68%), DWS ESG Biotech LC (0.09%), A4Investments SICAV SIF ACCI IlanaA2EURH (0.04%), Russell Inv US Small Cap Equity Y (0.04%).
What is DBV Technologies's short interest?
1.1M shares of DBV Technologies were sold short, 1.79% of the float; at the average daily volume it would take 3.29 days to cover.
Are insiders buying or selling DBV Technologies?
Of the latest 5 reported insider transactions in DBV Technologies (since May 22, 2025), 0 were purchases and 5 were sales.
How many shares of DBV Technologies are outstanding?
DBV Technologies has 62.8M shares outstanding, of which 31.9M are in the public float.